Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Assertio Therapeutics Inc 100 S. Saunders Road Suite 300 Lake Forest IL 60045 USA

www.assertiotx.com P: 224-419-7106 F: 510-744-8001

Description:

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.

Key Statistics

Overview:

Market Capitalization, $K 102,735
Enterprise Value, $K 67,805
Shares Outstanding, K 95,125
Annual Sales, $ 152,070 K
Annual Net Income, $ -331,940 K
Last Quarter Sales, $ 32,450 K
Last Quarter Net Income, $ -4,510 K
EBIT, $ 53,980 K
EBITDA, $ 82,660 K
60-Month Beta 0.92
% of Insider Shareholders 3.20%
% of Institutional Shareholders 48.96%
Float, K 92,081
% Float 96.80%
Short Volume Ratio 0.48

Growth:

1-Year Return -82.67%
3-Year Return -33.74%
5-Year Return -91.46%
5-Year Revenue Growth -51.22%
5-Year Earnings Growth -80.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 05/06/24
Next Earnings Date 08/01/24
Earnings Per Share ttm 0.23
EPS Growth vs. Prev Qtr -62.50%
EPS Growth vs. Prev Year 142.86%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 05/18/21

ASRT Ratios

Ratio
Price/Earnings ttm 4.78
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 10.80%
Return-on-Assets % 5.74%
Profit Margin % -218.28%
Debt/Equity 0.29
Price/Sales 0.69
Price/Cash Flow 1.36
Price/Book 0.70
Book Value/Share 1.41
Interest Coverage -74.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar